IPO Trending
INTEGRISMEDEQ / NSE, BSEUpcoming
Integris Medtech

Founded in 2008, Integris Medtech Ltd is a global medical products and laboratory solutions company based in India. It designs, manufactures, and sells a wide range of medical devices and lab equipment, focusing on cardiovascular care, diagnostics, and scientific research. With manufacturing units in India, Germany, and the Netherlands, the company serves over 65 international markets, catering to 9,500 laboratories and 2,000 hospitals. Its two main divisions include Cardiovascular Devices—offering stents, balloons, and vascular solutions—and Laboratory Solutions—providing instruments, reagents, consumables, and maintenance services under the BioCal brand. Integris Medtech operates across India, Europe, and Southeast Asia with strong brands like Chrome and Protégé, employing nearly 1,900 professionals and supporting global clinical research and patient care through innovation.

₹0 - ₹0GMP ₹0Open
GMP₹0
Est. Listing PriceTBA

Subscription Status

0Updated 31 Jan 2026, 05:21 PM
Upcoming IPOLive bidding data will appear once the issue opens.

This tab will start showing QIB, NII, Retail, and total demand as soon as bidding begins. Until then, use the offer window and price details below for planning.

Open DateTBA
Close DateTBA
Listing DateTBA
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Integris Medtech IPO Subscription Demand

Live subscription status and bidding analysis for Integris Medtech (INTEGRISMED) IPO. The issue is subscribed Tracking Live overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions